↓ Skip to main content

American Association for Cancer Research

BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte)

Overview of attention for article published in Clinical Cancer Research, July 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
2 news outlets
twitter
17 X users

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
136 Mendeley
Title
BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte)
Published in
Clinical Cancer Research, July 2020
DOI 10.1158/1078-0432.ccr-20-1427
Pubmed ID
Authors

Elise A. Chong, Lindsey E. Roeker, Mazyar Shadman, Matthew S. Davids, Stephen J. Schuster, Anthony R. Mato

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 136 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 15%
Other 15 11%
Student > Bachelor 15 11%
Student > Ph. D. Student 10 7%
Student > Master 10 7%
Other 32 24%
Unknown 34 25%
Readers by discipline Count As %
Medicine and Dentistry 37 27%
Biochemistry, Genetics and Molecular Biology 15 11%
Agricultural and Biological Sciences 9 7%
Nursing and Health Professions 6 4%
Immunology and Microbiology 3 2%
Other 27 20%
Unknown 39 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2021.
All research outputs
#1,170,736
of 22,765,347 outputs
Outputs from Clinical Cancer Research
#817
of 12,585 outputs
Outputs of similar age
#34,951
of 395,286 outputs
Outputs of similar age from Clinical Cancer Research
#33
of 225 outputs
Altmetric has tracked 22,765,347 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,585 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,286 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.